ValuationViz

KRYS fund manager activity

Krystal Biotech, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q1 2023 to Q2 2026.

Q2 2025

ManagerActivitySharesValue% of portfolioFiled
Joel Greenblatt - Gotham Asset ManagementSold out——0.00%Aug 14, 2025
Torray FundsNew11,574$1,590,9620.23%Aug 5, 2025

Q1 2025

ManagerActivitySharesValue% of portfolioFiled
Joel Greenblatt - Gotham Asset ManagementNew4,804$866,1610.01%May 15, 2025

Newer quarters · Older quarters